COVID-19, hydroxychloroquine and the eighth alternative.
作者信息
Chattopadhyay Arghya, Chaudhuri Kaushik
机构信息
Post Graduate Institute of Medical Education and Research, Chandigarh, India.
University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.
出版信息
Clin Med (Lond). 2020 Jul;20(4):e132-e133. doi: 10.7861/clinmed.Let.20.4.4.
Abstract
摘要
相似文献
1
COVID-19, hydroxychloroquine and the eighth alternative.新型冠状病毒肺炎、羟氯喹啉与第八种替代方案
Clin Med (Lond). 2020 Jul;20(4):e132-e133. doi: 10.7861/clinmed.Let.20.4.4.
2
Hydroxychloroquine and coronavirus disease 2019.羟氯喹与2019冠状病毒病
J R Coll Physicians Edinb. 2020 Jun;50(2):102-104. doi: 10.4997/JRCPE.2020.202.
3
The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale.羟氯喹与 COVID-19 ：一个警示故事。
Ann Intern Med. 2020 Oct 20;173(8):662-663. doi: 10.7326/M20-5041. Epub 2020 Jul 16.
4
Living evidence in response to controversies about the use of antimalarials in COVID-19.关于在新冠肺炎中使用抗疟药的争议的现存证据。
Rev Esp Cardiol (Engl Ed). 2020 Aug;73(8):693-694. doi: 10.1016/j.rec.2020.05.016. Epub 2020 May 29.
5
Why Your Patients' Believing Hydroxychloroquine and Chloroquine Are 90% Effective for COVID-19 Is 100% Dangerous.为何您的患者认为羟氯喹和氯喹对新冠病毒病有90%的疗效是极其危险的。
J Clin Pharmacol. 2020 Aug;60(8):949-953. doi: 10.1002/jcph.1687. Epub 2020 Jul 1.
6
Repurposing antimalarials and other drugs for COVID-19.将抗疟药及其他药物重新用于治疗新冠肺炎。
Travel Med Infect Dis. 2020 Mar-Apr;34:101658. doi: 10.1016/j.tmaid.2020.101658. Epub 2020 Apr 2.
7
Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?羟氯喹作为 COVID-19 的预防或治疗药物：证据说了什么？
Indian J Public Health. 2020 Jun;64(Supplement):S125-S127. doi: 10.4103/ijph.IJPH_496_20.
8
COVID-19 and Antimalarial Drugs: Harms Outweigh Benefits.新型冠状病毒肺炎与抗疟药物：弊大于利
Am J Crit Care. 2020 Nov 1;29(6):489-492. doi: 10.4037/ajcc2020694.
9
Regulators split on antimalarials for COVID-19.监管机构在用于治疗新冠肺炎的抗疟疾药物问题上存在分歧。
Lancet. 2020 Apr 11;395(10231):1179. doi: 10.1016/S0140-6736(20)30817-5.
10
QT Interval Control to Prevent Torsades de Pointes during Use of Hydroxychloroquine and/or Azithromycin in Patients with COVID-19.在新冠肺炎患者使用羟氯喹和/或阿奇霉素期间控制QT间期以预防尖端扭转型室速
Arq Bras Cardiol. 2020 Jun;114(6):1061-1066. doi: 10.36660/abc.20200389. Epub 2020 Jul 3.
本文引用的文献
1
Potential Shortages of Hydroxychloroquine for Patients with Lupus During the Coronavirus Disease 2019 Pandemic.2019年冠状病毒病大流行期间狼疮患者羟氯喹的潜在短缺情况。
JAMA Health Forum. 2020 Apr 1;1(4):e200438. doi: 10.1001/jamahealthforum.2020.0438.
2
Chloroquine and hydroxychloroquine in covid-19.氯喹和羟氯喹在2019冠状病毒病中的应用
BMJ. 2020 Apr 8;369:m1432. doi: 10.1136/bmj.m1432.
3
A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19.仓促下结论？有关羟氯喹治疗 COVID-19 的快速报告和结果传播及其后果。
Ann Intern Med. 2020 Jun 16;172(12):819-821. doi: 10.7326/M20-1223. Epub 2020 Mar 30.
4
Seven alternatives to evidence based medicine.循证医学的七种替代方法。
BMJ. 1999;319(7225):1618. doi: 10.1136/bmj.319.7225.1618.
5
Evidence-based medicine. A new approach to teaching the practice of medicine.循证医学。一种教授医学实践的新方法。
JAMA. 1992 Nov 4;268(17):2420-5. doi: 10.1001/jama.1992.03490170092032.
Zotero 插件